“Increase of fine might be effective, but need to be careful”

An expert member recognized that the revision for enlarging a fine on drug manufacturers, importers and sellers was valid, but also made a comment it was necessary to thoroughly consider its control over companies with small sales.

Expert Member Young-Hwan Seok at the National Assembly Health and Welfare Committee stated above about the partial revision bill to the Pharmaceutical Affairs Law t...